Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: FOLFOX+Panitumumab repeat every 14 days until discontinuance criteria. FOLFIRI+Panitumumab repeat every 14 days until discontinuance criteria. Primary outcome(s): Response Rate:RR Study Design: Parallel Non-randomized
创建时间：
2011-02-15
